Workflow
Knight Therapeutics Announces Relaunch of ORGOVYX® in Canada
Globenewswire· 2025-10-07 11:30
MONTREAL, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that it has relaunched ORGOVYX® (relugolix) in Canada. In June 2024, Knight and Sumitomo Pharma America Inc. (“SMPA”) announced that Knight and SMPA’s affiliates had entered into exclusive license and supply agreements to commercialize MYFEMBREE® (relugolix/estradiol/norethindrone acetate), ORGOVYX® (relugolix) and vibegron in Canada, as well a ...
Arq Schedules Third Quarter 2025 Earnings Conference Call
Globenewswire· 2025-10-07 11:30
GREENWOOD VILLAGE, Colo., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Arq, Inc. (NASDAQ: ARQ) (the "Company" or "Arq"), a producer of activated carbon and other environmentally efficient carbon products for use in purification and sustainable materials, today announced the Company will release its third quarter 2025 financial results and file its Quarterly Report on Form 10-Q for the period ended September 30, 2025 after market close on Wednesday, November 5, 2025. A conference call to discuss the Company's financial ...
Cartier Cuts 35.5 g/t Au over 0.5 m and 20.4 g/t Au over 0.5 m at Main (Cadillac); Confirms Near-Surface High-Grade Gold Potential; Advances Toward VG10 Zone
Globenewswire· 2025-10-07 11:30
VAL-D’OR, Quebec, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Cartier Resources Inc. (″ Cartier ″ or the ″ Company ″) (TSXV: ECR; FSE: 6CA) is pleased to announce the second batch of results from Main Sector and more precisely, the VG9 Zone, from the fully funded 100,000-m drilling program (2 drill rigs) on its 100%-owned Cadillac Project, located in Val-d’Or (Abitibi, Quebec). Strategic Highlights from Main Sector Drill Results of VG9 Zone (Figures 1 & 2) Hole CA25-261 intersected 35.5 g/t Au over 0.5 m with visible ...
Allied Provides Leasing Update
Globenewswire· 2025-10-07 11:25
文章核心观点 - 加拿大主要城市对城市办公空间的需求强劲,但供应量正在减少,这导致潜在租户的紧迫感增强 [1] - 公司在蒙特利尔和温哥华以及其Allied Modern资产组合部分的空置面积租赁取得进展,但多伦多和Allied Heritage部分的租赁速度低于预期,导致年底无法实现90%的出租和使用面积目标 [1] 蒙特利尔租赁进展 - 位于1001 Robert-Bourassa大道的物业经过改造后,成功吸引大型成熟用户 [2] - 一个重要现有用户进行了两次扩租,首次扩租15,000平方英尺,随后再次扩租100,233平方英尺,均于今年10月1日生效,使其总租赁面积达到246,729平方英尺 [2] - 该大楼目前出租率达到86% [2] 温哥华租赁进展 - 租赁400 West Georgia物业的最后四层是2025年的优先事项 [3] - 公司已与一家全球教育机构敲定了49,105平方英尺(共四层中的三层)的长期租约,仅待11月底前完成常规监管审批 [3] - 该大楼目前出租率为96%,公司预计最后一层将由楼内现有用户租用 [3] 其他资产租赁与运营 - 公司现已完全拥有M4物业,并与Netflix敲定了26,112平方英尺的租约扩展,使Netflix在该楼的总面积达到136,544平方英尺 [4] - M4大楼目前的出租率为90% [4] - 公司任命J P Mackay为高级副总裁兼首席运营官,以认可其过去几年对全国运营的贡献 [5] - 公司任命Gord Oughton为高级副总裁兼全国租赁主管,以认可其承担全国租赁职责 [5] - 管理层认为,加强后的全国统一团队有助于公司利用加拿大主要城市办公市场基本面的改善 [6] 公司背景 - 公司是加拿大主要城市中特色城市工作空间的领先业主和运营商 [8] - 公司的使命是为知识型组织提供可持续且有利于员工健康、创造力、连通性和多样性的工作空间 [8]
Sound Group Announces Cancellation of Repurchased Shares
Globenewswire· 2025-10-07 11:15
股份回购计划完成情况 - 公司已完成其400万美元股份回购计划 回购并注销了951,252股美国存托股票[1] - 回购总对价为3,999,984.99美元 几乎用尽了全部授权资金[2] - 此次注销后 公司已发行普通股总数约为8.32亿股 相当于416万股美国存托股票[2] 管理层评论与战略意图 - 公司创始人兼CEO表示 通过回购并减少流通股数量 提升了每股收益[3] - 此举旨在兑现为股东创造价值的承诺 并显示对公司内在价值的信心[3] - 公司拥有稳健的资产负债表 对长期增长前景保持信心 并将继续推进战略计划[3] - 随着回购和现金分红计划均已完成 公司正积极寻求更多机会为股东回报价值[3] 公司背景信息 - Sound Group Inc是一家以音频为核心的全球社交和娱乐公司[4] - 公司致力于构建全球最大的音频平台以更好地连接和沟通[4] - 公司自2020年1月起在纳斯达克上市[4]
NeoVolta Enters Into Asset Purchase Agreement for Neubau Energy's Next-Generation Battery Platform; Expects Transaction to Be Immediately Accretive to Revenues and Gross Margins
Globenewswire· 2025-10-07 11:05
Neubau executives join NeoVolta as Chief Operating Officer and Chief Technology OfficerSAN DIEGO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- NeoVolta Inc. (NASDAQ: NEOV) entered into on October 1, 2025 an asset purchase agreement for the purchase of strategic assets of Neubau Energy pursuant to its letter of intent announced on September 10, 2025 [link]. The acquisition is expected to close by October 15, 2025. Concurrently, NeoVolta hired Neubau executives, naming Amany Ibrahim as chief operating officer and Thomas ...
Jade Biosciences Announces JADE201, a Potentially Best-in-Class Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody in Development for Autoimmune Diseases
Globenewswire· 2025-10-07 11:05
JADE201 builds on clinical proof-of-concept for BAFF-R targeting, adding half-life extension technology to provide extended receptor occupancy with the goal of delivering deeper, more durable B cell depletion with less frequent subcutaneous dosing JADE201’s high affinity binding and extended half-life enabled dose-dependent BAFF receptor occupancy and sustained B cell depletion in non-human primatesFirst-in-human trial in rheumatoid arthritis expected to begin in the first half of 2026; potential for broad ...
Hudbay Resumes Operations in Peru
Globenewswire· 2025-10-07 11:00
TORONTO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) announces it has resumed operations at the Constancia mine in Peru following a temporary shutdown due to local protests and illegal blockades. The safety of all personnel is the Company’s top priority, and Hudbay suspended operations on September 22nd as a precaution to ensure the safety of personnel and allow time for the authorities to address the illegal protests. Hudbay has recently restarted ope ...
GXO Renews Partnership with Dolce&Gabbana Beauty
Globenewswire· 2025-10-07 11:00
GXO's expertise in beauty logistics ensures efficiency and exceptional service, supporting Dolce&Gabbana Beauty’s exponential growth MILAN, Italy, Oct. 07, 2025 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO), the world's largest pure-play contract logistics provider, announced today that it has renewed its long-term partnership with Dolce&Gabbana Beauty. The agreement includes management of the client's new dedicated warehouse in Calvenzano (BG), Italy, including handling retail and wholesale orders fo ...
Jade Biosciences Announces $135 Million Private Placement
Globenewswire· 2025-10-07 11:00
SAN FRANCISCO and VANCOUVER, British Columbia, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“the Company” or “Jade”), (Nasdaq: JBIO), a clinical-stage biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced that it has entered into a securities purchase agreement for a private investment in public equity (“PIPE”) financing that is expected to result in gross proceeds of approximately $135 million to the Company, before placement agent fees an ...